Medtronic gets US clearance for Thera-i pacemakers:
This article was originally published in Clinica
Medtronic has received FDA clearance for its Thera i-series pacemakers just in time to launch them at the American Heart Association meeting in Anaheim (November 11th-14th). The four i-series devices are about the same size as their Thera predecessors, but have greater longevity and have been re-shaped to make them easier to implant. At the top of the range, the dual chamber, rate-responsive, DR-i has improved automatic mode switching, to prevent inappropriate pacing during atrial flutter. The Thera series was approved in the US in January (see Clinica No 638, p 20) and the i-series was launched in Europe in July (see Clinica No 667, p 16).